Piper Jaffray Raises Price Target on Vascular Solutions (VASC) Following First Earnings Report Since DOJ Litigation
Piper Jaffray reiterated an Overweight rating on Vascular Solutions (NASDAQ: VASC), and raised the price target to $45.00 (from $44.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)